Analyzing Pain Patterns in the Emergency Department: Leveraging Clinical Text Deep Learning Models for Real-World Insights

Objective: To estimate the prevalence of patients presenting in pain to an inner-city emergency department (ED), describing this population, their treatment, and the effect of the COVID-19 pandemic. Materials and Methods: We applied a clinical text deep learning model to the free text nursing assessments to identify the prevalence of pain on arrival to the ED. Using interrupted time series analysis, we examined the prevalence over three years. We describe this population pre- and post-pandemic in terms of their demographics, arrival patterns and treatment. Results: 55.16% (95%CI 54.95% - 55.36%) of all patients presenting to this ED had pain on arrival. There were significant differences in demographics, arrival and departure patterns between those patients with and without pain. The COVID-19 pandemic initially precipitated a decrease followed by a sharp, sustained rise in the prevalence of pain on arrival, altering the population arriving in pain and their treatment. Discussion The application of a clinical text deep learning model has successfully identified the prevalence of pain on arrival. The description of this population and their treatment forms the basis of intervention to improve care for patients presenting with pain. The combination of the clinical text deep learning model and interrupted time series analysis has identified the effects of the COVID-19 pandemic on pain care in the ED. Conclusion A clinical text deep learning model has led to identifying the prevalence of pain on arrival and was able to identify the effect a major pandemic had on pain care in this ED. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was funded by the Emergency Medicine Foundation. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Royal Brisbane and Women's Hospital Human Research Ethics Committee I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Due to local regulations this data is not available